Form 4: Dexcom Director Transfers Shares to Trust

Karen M. Dahut, a director at Dexcom Inc., transferred shares of common stock from direct ownership to a trust, according to a recent SEC filing.

Summary

• On May 8, 2025, Karen M. Dahut, a director of Dexcom Inc. (DXCM), transferred 2,613 shares of Dexcom common stock from direct ownership to the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST.
• The transfer occurred upon the vesting of previously awarded restricted stock units.
• Following the transaction, Dahut directly owns 0 shares and indirectly owns 17,779 shares through the trust.
• Dahut is a trustee of the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST, dated June 14, 2005.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a share transfer, which has a neutral sentiment.

Industry Context

This is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. These transactions are closely watched by investors for signals about management's confidence in the company's future prospects.

Stakeholder Impact

• The transaction itself is unlikely to have a significant impact on stakeholders, as it is a transfer of ownership between the director and a trust controlled by the director.

Key Dates

Keywords

Dexcom, Director, Share Transfer, Trust, Form 4, DXCM, Karen M. Dahut, Beneficial Ownership, Securities, Stock